Lipocine to Share Cirrhosis Treatment LPCN 1148 Results at The Liver Meeting

By Emon Reiser Lipocine said the results of its Phase 2 study evaluating LPCN 1148, a treatment to manage decompensated cirrhosis, will be presented at the...

Related Keywords

Boston ,Massachusetts ,United States ,American ,Mahesh Patel ,Tarun Sanyal ,Stravitz Sanyal Institute For Liver Disease ,Metabolic Health At Virginia Commonwealth University ,American Association ,Liver Disease The ,Stravitz Sanyal Institute ,Liver Disease ,Metabolic Health ,Virginia Commonwealth ,Executive Mahesh Patel ,Liver Meeting ,Emon Reiser ,Article Normal ,Synd ,Us53630x2036 ,Lpcn ,